most of the facts are on the table. Lost digicel and a sheet 4c. This acquisition want change these facts and will be too small to make an impact. BUD can’t afford a big acquisition.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025